Iron Deficiencies Clinical Trials

12 recruitingLast updated: June 20, 2026

There are 12 actively recruiting iron deficiencies clinical trials across 9 countries. Studies span Not Applicable, Early Phase 1, Phase 3, Phase 4. Top locations include Barcelona, Spain, Beijing, China, El Palmar, Murcia, Spain. Updated daily from ClinicalTrials.gov.


Iron Deficiencies Trials at a Glance

12 actively recruiting trials for iron deficiencies are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Barcelona, Beijing, and El Palmar. Lead sponsors running iron deficiencies studies include China-Japan Friendship Hospital, Columbia University, and Cajal Therapeutics Inc..

Browse iron deficiencies trials by phase

Treatments under study

About Iron Deficiencies Clinical Trials

Looking for clinical trials for Iron Deficiencies? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Iron Deficiencies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Iron Deficiencies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Early Phase 1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Chronic Kidney DiseaseIron DeficienciesAnemia
Cajal Therapeutics Inc.72 enrolled1 locationNCT07577817
Recruiting

Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women

ContraceptionIron Deficiencies
United States Army Research Institute of Environmental Medicine33 enrolled1 locationNCT06909695
Recruiting
Not Applicable

Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia

Celiac Disease in ChildrenIron DeficienciesAnemia
Istituto Giannina Gaslini60 enrolled1 locationNCT07563582
Recruiting
Not Applicable

A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising Females

Low ferritinIron DeficienciesIron-deficiency+1 more
Lindenwood University30 enrolled1 locationNCT07546591
Recruiting
Not Applicable

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

Iron DeficienciesAnemiaCardiac Surgery
Second Affiliated Hospital, School of Medicine, Zhejiang University400 enrolled1 locationNCT06968936
Recruiting
Phase 4

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

Elderly (People Aged 65 or More)Iron Deficienciesacute coronary syndromes (ACS)
Fundación para la Investigación del Hospital Clínico de Valencia538 enrolled9 locationsNCT07476859
Recruiting
Not Applicable

Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya

Iron AbsorptionIron DeficienciesSeverly Acutely Malnourished Children+2 more
ETH Zurich68 enrolled2 locationsNCT07315295
Recruiting
Not Applicable

Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

ObesityBariatric SurgeryIron Deficiencies+1 more
China-Japan Friendship Hospital200 enrolled1 locationNCT07236788
Recruiting
Not Applicable

Kids With Iron Deficiency and Scoliosis

Perioperative/Postoperative ComplicationsAdolescent Idiopathic ScoliosisIron Deficiencies+4 more
Columbia University275 enrolled1 locationNCT06042699
Recruiting
Phase 3

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Iron DeficienciesChronic Heart Failure
Pharmacosmos A/S1,900 enrolled1 locationNCT06929806
Recruiting

IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure

Heart FailureIron Deficiencies
University Hospital Southampton NHS Foundation Trust16 enrolled1 locationNCT06542822
Recruiting

Effect of Non-anemic Iron Deficiency on Outcome Following Off-pump Coronary Revascularization

Iron DeficienciesCoronary Artery Bypass, Off-Pump
Yonsei University433 enrolled1 locationNCT06399627